SG145760A1 - Compositions for purifying and crystallizing molecules of interest - Google Patents
Compositions for purifying and crystallizing molecules of interestInfo
- Publication number
- SG145760A1 SG145760A1 SG200806175-6A SG2008061756A SG145760A1 SG 145760 A1 SG145760 A1 SG 145760A1 SG 2008061756 A SG2008061756 A SG 2008061756A SG 145760 A1 SG145760 A1 SG 145760A1
- Authority
- SG
- Singapore
- Prior art keywords
- interest
- compositions
- purifying
- composition
- crystallizing molecules
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000003446 ligand Substances 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15708603A IL157086A0 (en) | 2003-07-24 | 2003-07-24 | Multivalent ligand complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG145760A1 true SG145760A1 (en) | 2008-09-29 |
Family
ID=32652285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200806175-6A SG145760A1 (en) | 2003-07-24 | 2004-07-22 | Compositions for purifying and crystallizing molecules of interest |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060121519A1 (https=) |
| EP (1) | EP1648995A4 (https=) |
| JP (1) | JP2007515384A (https=) |
| KR (1) | KR20060037337A (https=) |
| CN (1) | CN101415721A (https=) |
| CA (1) | CA2531492A1 (https=) |
| IL (2) | IL157086A0 (https=) |
| MX (1) | MXPA06000944A (https=) |
| NO (1) | NO20060400L (https=) |
| RU (1) | RU2006105648A (https=) |
| SG (1) | SG145760A1 (https=) |
| WO (1) | WO2005010141A2 (https=) |
| ZA (1) | ZA200600315B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7956165B2 (en) | 2003-07-24 | 2011-06-07 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
| WO2006085321A2 (en) * | 2005-02-10 | 2006-08-17 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
| FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
| US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
| WO2008079302A2 (en) * | 2006-12-21 | 2008-07-03 | Millipore Corporation | Purification of proteins |
| US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
| US20100233714A1 (en) * | 2007-11-13 | 2010-09-16 | Beadling Leslie C | Multistate affinity ligands for the separation and purification of antibodies, antibody fragments and conjugates of |
| WO2009078018A2 (en) * | 2007-12-17 | 2009-06-25 | Affisink Biotechnology Ltd. | Methods for purifying or depleting molecules or cells of interest |
| US8999702B2 (en) | 2008-06-11 | 2015-04-07 | Emd Millipore Corporation | Stirred tank bioreactor |
| JP2012511929A (ja) | 2008-12-16 | 2012-05-31 | イー・エム・デイー・ミリポア・コーポレイシヨン | 攪拌タンク反応器及び方法 |
| CA2791918C (en) | 2010-03-05 | 2019-11-19 | Boehringer Ingelheim International Gmbh | Selective enrichment of antibodies |
| WO2011146394A1 (en) | 2010-05-17 | 2011-11-24 | Millipore Corporation | Stimulus responsive polymers for the purification of biomolecules |
| US10030224B2 (en) | 2015-11-01 | 2018-07-24 | Ariel-University Research And Development Company Ltd. | Methods of analyzing cell membranes |
| WO2021152584A1 (en) | 2020-01-28 | 2021-08-05 | Ariel Scientific Innovations Ltd. | Methods of analyzing cell membranes |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) * | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US5215927A (en) * | 1986-01-30 | 1993-06-01 | Fred Hutchinson Cancer Research Center | Method for immunoselection of cells using avidin and biotin |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6740734B1 (en) * | 1994-01-14 | 2004-05-25 | Biovitrum Ab | Bacterial receptor structures |
| SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US6017719A (en) * | 1994-06-14 | 2000-01-25 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
| US20010008766A1 (en) * | 1998-03-17 | 2001-07-19 | Sylvia Daunert | Quantitative binding assays using green fluorescent protein as a label |
| US6589503B1 (en) * | 1998-06-20 | 2003-07-08 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US7198930B2 (en) * | 2000-02-29 | 2007-04-03 | Millennium Pharmaceuticals, Inc. | Human protein kinase, phosphatase, and protease family members and uses thereof |
| DE60231801D1 (de) * | 2001-04-23 | 2009-05-14 | Mallinckrodt Inc | Tc und re markierte radioaktive glycosylierte octreotid-derivate |
| US20040265921A1 (en) * | 2003-06-30 | 2004-12-30 | National University Of Singapore | Intein-mediated attachment of ligands to proteins for immobilization onto a support |
| US7956165B2 (en) * | 2003-07-24 | 2011-06-07 | Affisink Biotechnology Ltd. | Compositions and methods for purifying and crystallizing molecules of interest |
-
2003
- 2003-07-24 IL IL15708603A patent/IL157086A0/xx unknown
-
2004
- 2004-07-22 SG SG200806175-6A patent/SG145760A1/en unknown
- 2004-07-22 WO PCT/IL2004/000669 patent/WO2005010141A2/en not_active Ceased
- 2004-07-22 MX MXPA06000944A patent/MXPA06000944A/es not_active Application Discontinuation
- 2004-07-22 KR KR1020067000635A patent/KR20060037337A/ko not_active Withdrawn
- 2004-07-22 CA CA002531492A patent/CA2531492A1/en not_active Abandoned
- 2004-07-22 CN CNA2004800263533A patent/CN101415721A/zh active Pending
- 2004-07-22 RU RU2006105648/13A patent/RU2006105648A/ru not_active Application Discontinuation
- 2004-07-22 JP JP2006520982A patent/JP2007515384A/ja active Pending
- 2004-07-22 EP EP04745009A patent/EP1648995A4/en not_active Withdrawn
-
2006
- 2006-01-12 IL IL173107A patent/IL173107A0/en unknown
- 2006-01-12 ZA ZA200600315A patent/ZA200600315B/xx unknown
- 2006-01-12 US US11/330,112 patent/US20060121519A1/en not_active Abandoned
- 2006-01-25 NO NO20060400A patent/NO20060400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20060121519A1 (en) | 2006-06-08 |
| EP1648995A2 (en) | 2006-04-26 |
| WO2005010141A2 (en) | 2005-02-03 |
| CA2531492A1 (en) | 2005-02-03 |
| ZA200600315B (en) | 2007-04-25 |
| EP1648995A4 (en) | 2010-03-10 |
| WO2005010141A3 (en) | 2009-03-26 |
| NO20060400L (no) | 2006-03-27 |
| KR20060037337A (ko) | 2006-05-03 |
| IL173107A0 (en) | 2006-06-11 |
| RU2006105648A (ru) | 2006-07-27 |
| MXPA06000944A (es) | 2006-03-30 |
| CN101415721A (zh) | 2009-04-22 |
| JP2007515384A (ja) | 2007-06-14 |
| IL157086A0 (en) | 2004-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG145760A1 (en) | Compositions for purifying and crystallizing molecules of interest | |
| Lu et al. | Dimethylformamide: an unusual glycosylation modulator | |
| Ibrahim et al. | Callyaerins A–F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa | |
| WO2004094635A3 (en) | Compositions and methods for using a solid support to purify rna | |
| WO2009010976A3 (en) | Compositions and methods for purifying and crystallizing molecules of interest | |
| ES2391043T3 (es) | Procedimiento para preparar inhibidores de nucleósido fosforilasas y nucleosidadas | |
| AP1709A (en) | Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof. | |
| MX2007013632A (es) | Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios. | |
| SE0300119D0 (sv) | Novel compounds | |
| WO2003087301A3 (en) | Methods and compositions for dna manipulation | |
| PT1268471E (pt) | Derivados n-heterociclicos como inibidores de nos | |
| DE69934242D1 (de) | Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen | |
| BRPI0410685B8 (pt) | processos de purificação do 1,3-propanodiol e composição | |
| WO2006069001A3 (en) | Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands | |
| MY147262A (en) | 1-aza-bicyclo[3.3.1]nonanes | |
| Tsakos et al. | The rakicidin family of anticancer natural products–synthetic strategies towards a new class of hypoxia-selective cytotoxins | |
| WO2001096373A3 (en) | Fluorescent timer proteins and methods for their use | |
| AU4854999A (en) | Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule | |
| WO2006085321A3 (en) | Compositions and methods for purifying and crystallizing molecules of interest | |
| WO2002086155A3 (en) | Method for the preferential nucleic acid amplification of selected nucleic acid regions | |
| Vangala et al. | p-Nitrophenyl carbonate promoted ring-opening reactions of DBU and DBN affording lactam carbamates | |
| TW200502238A (en) | Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds | |
| WO2001079167A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| Thomas et al. | Distamycin Analogues without Leading Amide at Their N‐Termini− Comparative Binding Properties to AT‐and GC‐Rich DNA Sequences | |
| MXNL02000026A (es) | Metodo para preparar cargas pre-reaccionadas de materias primas para la produccion de formulas de vidrio. |